The relationship between mean plate- let volume and high on-treatment platelet reactivity (Author`s Reply)

References (3)

1. Jakl M, Sevcik R, Ceral J, Fatorova I, Horacek JM, Vojacek J. Mean platelet volume and platelet count: overlooked markers of high on-treatment platelet reactivity and worse outcome in patients with acute coronary syndrome
2. Lance MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol 2010; 16: 28-31. [CrossRef] 3. Loreth RM, Klose G. Comparison of two different blood sample tubes for platelet function analysis with the Multiplate(R) system. Transfus Med Hemother 2010; 37: 289-92. [CrossRef] 4. Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, et al. Mean platelet volume may represent a predictive parameter for over- all vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011; 31: 1215-8. [CrossRef] 5. Kandis H, Ozhan H, Ordu S, Erden I, Cağlar O, Başar C, et al. The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J 2011; 28: 575-8. [CrossRef] 6. Arıkanoğlu A, Yücel Y, Acar A, Çevik MU, Akıl E, Varol S. The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients. Eur Rev Med Pharmacol Sci 2013; 17: 1774-7
3. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207. [CrossRef]